Beth Israel Deaconess | GenomeWeb

Beth Israel Deaconess

The company is preparing a blood-based test for early-stage pancreatic cancer that it hopes to have on the market by 2019.

The prospective multi-site research study aims to determine the mutation prevalence of pancreatic cancer patients with a hereditary predisposition to the disease.

The researchers are following up on earlier NIH-funded work examining microRNAs as potential indicators of clinical outcomes of heart disease patients.

Six out of 61 miRNAs in a prospective cardiovascular disease study could be reliably measured from plasma samples after more than a dozen years in liquid nitrogen.

Using epigenetic data, expression profiles, gene editing, and more, researchers uncovered interactions in fat precursor cells that may explain FTO's role in obesity.

Using Quanterix's Simoa technology, the group developed assays to detect C. diff toxins with a high degree of sensitivity and specificity.

NEW YORK (GenomeWeb) – The Jackson Laboratory and Boston's Beth Israel Deaconess Medical Center have partnered to launch clinical genomics initiatives targeting new diagnostics and treatments and collaborative genomic education programs, Jackson Lab said on Monday.

NEW YORK (GenomeWeb) – Cancer Genetics and Beth Israel Deaconess Medical Center have partnered to study genomic biomarkers in non-Hodgkin lymphoma patients and correlate those markers with clinical outcomes, CGI said today.

NEW YORK (GenomeWeb) – The Cancer Center at Beth Israel Deaconess Medical Center (BIDMC) has just launched the Institute for RNA Medicine (IRM), an initiative that aims to bring together scientists from across the Harvard Medical School community to study and develop RNA-based therapeutics for ca

Clinical researchers at Beth Israel Deaconess Medical Center and Harvard Medical School have teamed up with RainDance Technologies to explore the use of RainDance's picodroplet-based digital PCR platform to measure microRNA biomarkers in the blood of patients undergoing various c

Pages

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.